NCT00215449
已完成
3 期
Study in Patients With COPD
Dey1 个研究点 分布在 1 个国家目标入组 690 人2005年9月22日
适应症COPD
概览
- 阶段
- 3 期
- 干预措施
- 未指定
- 疾病 / 适应症
- COPD
- 发起方
- Dey
- 入组人数
- 690
- 试验地点
- 1
- 主要终点
- Measure of lung function
- 状态
- 已完成
- 最后更新
- 15年前
概览
简要总结
The purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.
研究者
入排标准
入选标准
- •Medical diagnosis of COPD
- •Current or prior history of cigarette smoking
排除标准
- •Medical diagnosis of asthma
- •Chest x-ray (CXR) prior to Day 1 diagnostic of significant disease other than COPD
- •Significant condition or disease other than COPD
结局指标
主要结局
Measure of lung function
次要结局
- Change in lung function, as well as vital signs
- Physical Exam results, Adverse Event reporting, etc
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Study in Patients With COPDCOPDNCT00215384Dey35
已完成
2 期
Study in Patients With COPDCOPDChronic Obstructive Pulmonary DiseaseNCT00215423Dey49
已完成
2 期
A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPDCOPDNCT06003049RMW Testing40
已完成
不适用
Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.Chronic Obstructive Pulmonary Disease (COPD)NCT01260389University Hospital, Ghent734
已完成
2 期
A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)Pulmonary Disease, Chronic ObstructiveChronic Obstructive Pulmonary Disease (COPD)NCT00392587GlaxoSmithKline30